ArticleJournal of managed care & specialty pharmacy2024

Tirzepatide 10 and 15 mg vs semaglutide 2.0 mg: A long-term cost-effectiveness analysis in patients with type 2 diabetes in the United States.

Reema Mody et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.